Featured Articles

1. Building the Next Generation of TIDES Manufacturing Excellence 2/12/2026

   Rising demand for complex TIDES therapies is shifting manufacturing expectations, driving adoption of continuous processing, digital tools, stronger supply strategies, and greener, scalable synthesis.

2. Inside The Shift Toward Greener, Faster, Smarter Drug Manufacturing 2/12/2026

   Manufacturers are using continuous processing, analytics, and enzyme‑driven chemistry to cut waste, accelerate development, and enable safer, adaptable workflows amid rising sustainability demands.

3. Unlocking The Potential Of Biocatalysis 1/22/2026

   Biocatalysis delivers cleaner, more selective pharma processes while cutting energy use and waste. Engineered enzymes broaden their reach, enabling faster development and greater sustainability.

4. Leveraging Flow Chemistry 1/22/2026

   Discover how continuous processing cuts waste, improves efficiency, and supports safer, scalable reactions while helping teams meet sustainability goals and speed development.

5. AsymBio Commences Commercial Operations At Fengxian Base 12/8/2025

   Shanghai, AsymBio, a technology-driven global Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), today announced the official start of commercial production at its Shanghai Fengxian Commercial Manufacturing Base.

6. Oligo-Ready 8/17/2022

   The benefits of continuous flow manufacturing are significant and numerous and those benefits grow with each technological breakthrough and methodological advance.

7. Continuous Flow Ready 8/17/2022

   The benefits of continuous flow manufacturing are significant and numerous and those benefits grow with each technological breakthrough and methodological advance.

8. Continuous Flow/Batch Manufacturing Mix 4/8/2022

   Many factors can necessitate a mix of continuous flow and batch manufacturing processes, which is often the first step towards multi-step flow processes. Review two examples.

9. Enhance Reaction Rates For Anti-Cancer Therapy Manufacture 4/8/2022

   Applying flow chemistry techniques allowed for a new route for an experimental anti-cancer therapy which included LED-NMR reaction profiling, quantum yield measurements and Stern-Volmer quenching studies.

10. A Better Route For Commercial Manufacture: Improved Yields And Operability 4/8/2022

    A new process was needed for the commercial manufacturing of Ceralasertib, an experimental anti-cancer therapy with a challenging molecular structure.